| 2/14/2025 | IG | Market Commentary: IG bond issuance cools; post-holiday makeup builds; Eli Lilly, Pepsi short tenors tight
|
| 2/10/2025 | GNIG | S&P gives A+ to Eli Lilly notes
|
| 2/10/2025 | IG | Eli Lilly preps six-part note offering via five bookrunners
|
| 8/12/2024 | IG | New Issue: Eli Lilly prices $5 billion of senior notes in five tranches
|
| 8/12/2024 | IG | Eli Lilly preps five-part note offering via five bookrunners
|
| 2/7/2024 | IG | New Issue: Eli Lilly prices $6.5 billion of senior notes in five tranches
|
| 2/7/2024 | GNIG | S&P assigns A+ to Eli Lilly notes
|
| 2/7/2024 | IG | Eli Lilly readies five-part note offering via five bookrunners
|
| 2/7/2024 | GNIG | Moody’s rates Eli Lilly notes A1
|
| 2/24/2023 | IG | Market Commentary: IG bond supply slows ahead of expected pickup; fund inflows decline; ETF inflows up
|
| 2/23/2023 | IG | New Issue: Eli Lilly prices $4 billion of senior notes in four tranches
|
| 2/23/2023 | GNIG | S&P assigns A+ to Eli Lilly notes
|
| 2/23/2023 | IG | Eli Lilly readies four-part note offering via four bookrunners
|
| 12/5/2022 | GNIG | Moody’s alters Lilly view to positive
|
| 2/7/2022 | GNIG | S&P shifts Eli Lilly view to stable
|
| 9/8/2021 | GNIG | Moody's rates Eli Lilly's notes A2
|
| 9/8/2021 | GNIG | S&P gives A+ to Eli Lilly notes
|
| 8/21/2020 | IG | Market Commentary: High-grade supply remains strong; lighter action eyed to close out August; new issues mixed
|
| 8/21/2020 | IG | Market Commentary: Morning Commentary: Investment-grade supply quiets after strong week; new issues mixed
|
| 8/20/2020 | IG | Market Commentary: Johnson & Johnson, Eli Lilly, Principal Life, IFC price notes; high-grade inflows decline
|
| 8/20/2020 | IG | S&P gives Eli Lilly notes A+
|
| 8/20/2020 | IG | New Issue: Eli Lilly prices $1.1 billion of senior notes in new, reopened tranches
|
| 8/20/2020 | IG | S&P gives Eli Lilly notes A+
|
| 8/20/2020 | IG | Market Commentary: Morning Commentary: Johnson & Johnson, Eli Lilly, Principal Life, IFC to price notes
|
| 4/24/2020 | IG | Market Commentary: Eli Lilly, Texas Instruments, Fairfax price; Biogen, Delta Air on tap; bank paper improves
|
| 4/24/2020 | IG | New Issue: Eli Lilly prices $1 billion 2.25% 30-year senior notes at 110 bps over Treasuries
|
| 4/24/2020 | IG | Market Commentary: Morning Commentary: High-grade issuers Eli Lilly, Texas Instruments in Friday pipeline
|
| 4/24/2020 | IG | S&P rates Eli Lilly notes A+
|
| 4/24/2020 | IG | Eli Lilly plans to sell fixed-rate notes via four bookrunners
|
| 3/3/2020 | IG | S&P trims General Dynamics
|
| 3/3/2020 | IG | S&P shifts Eli Lilly view to negative
|
| 2/20/2019 | IG | Market Commentary: Eli Lilly, Prudential, Whirlpool, CBS, Hudson, KfW, BNG, Council of Europe tap primary
|
| 2/20/2019 | IG | New Issue: Eli Lilly prices $4.5 billion of senior notes in four tranches
|
| 2/20/2019 | IG | S&P rates Eli Lilly notes A+
|
| 2/20/2019 | IG | Eli Lilly plans to price fixed-rate notes in four tranches
|
| 2/19/2019 | IG | S&P lowers Eli Lilly
|
| 1/8/2019 | IG | S&P puts Eli Lilly on negative watch
|
| 5/4/2017 | IG | Market Commentary: Apple, Eli Lilly, General Motors Financial, EnLink tap primary market; Apple notes soften
|
| 5/4/2017 | IG | Fitch rates Eli Lilly notes A
|
| 5/4/2017 | IG | S&P rates Eli Lilly notes AA-
|
| 5/4/2017 | IG | New Issue: Eli Lilly prices $2.25 billion of fixed-rate notes in three tranches
|
| 5/4/2017 | IG | Moody’s rates Eli Lilly notes A2
|
| 5/4/2017 | IG | Eli Lilly intends to price fixed-rate notes in three tranches
|
| 11/23/2016 | IG | Moody’s: Eli Lilly drug failure is credit negative
|
| 10/5/2016 | IG | Moody’s: Eli Lilly unaffected by acquisition
|
| 5/10/2016 | IG | Fitch rates Eli Lilly bond A
|
| 5/10/2016 | IG | Moody’s assigns A2 to Eli Lilly notes
|
| 5/10/2016 | IG | S&P rates Eli Lilly bond AA-
|
| 5/28/2015 | IGLM | Eli Lilly gets early tenders for $1.45 billion of notes; pricing set
|
| 5/26/2015 | IG | S&P rates Eli Lilly bond AA-
|
| 5/26/2015 | IG | Fitch: Eli Lilly euro notes A
|
| 5/26/2015 | IG | Moody’s applies A2 to Eli Lilly euro notes
|
| 5/12/2015 | IGLM | Eli Lilly tenders for up to $1.6 billion of bonds, calls 6.57% notes
|
| 2/27/2015 | IG | Market Commentary: Morning Commentary: Juniper Networks notes tighten, Eli Lilly improves in early trade
|
| 2/26/2015 | IG | Market Commentary: Morning Commentary: Chevron, Eli Lilly senior notes firm 4 bps to 5 bps in secondary trading
|
| 2/24/2015 | IG | Market Commentary: Busy primary sees Chevron, Eli Lilly, Kimberly-Clark do deals; AT&T firms; Southwestern mixed
|
| 2/24/2015 | IG | New Issue: Eli Lilly prices $2.2 billion of notes in three tranches
|
| 2/24/2015 | IG | Fitch rates Eli Lilly notes A
|
| 2/24/2015 | IG | Moody's rates Eli Lilly notes A2
|
| 2/24/2015 | IG | S&P assigns Eli Lilly notes AA-
|
| 2/24/2015 | IG | Eli Lilly plans benchmark three-part notes offering
|
| 4/24/2014 | IG | Fitch affirms Eli Lilly on acquisition news
|
| 4/22/2014 | IG | Moody's affirms Eli Lilly
|
| 2/24/2014 | IG | Market Commentary: Midday Commentary: Investment-grade bonds stable; Eli Lilly notes firm; Google trades flat
|
| 2/21/2014 | IG | Fitch rates Eli Lilly notes A
|
| 2/20/2014 | IG | New Issue: Eli Lilly prices upsized $1 billion issue in five-, 30-year tranches
|
| 2/20/2014 | IG | S&P rates Eli Lilly notes AA-
|
| 2/20/2014 | IG | Moody's assigns Eli Lilly notes A2
|
| 2/20/2014 | IG | Market Commentary: Canada, Google, Whirlpool deals price tight; Eli Lilly joins primary; Google eases, then firms
|
| 2/20/2014 | IG | Eli Lilly plans $800 million two-part notes in five-, 30-year tranches
|
| 11/3/2011 | IG | Fitch downgrades Eli Lilly
|
| 11/8/2010 | IG | Moody's cuts Eli Lilly
|
| 11/3/2010 | IG | Fitch affirms Eli Lilly
|
| 10/20/2010 | IG | Moody's may cut Eli Lilly
|
| 8/19/2010 | IG | S&P cuts Eli Lilly
|
| 5/21/2010 | IG | Moody's: Eli Lilly outlook negative
|
| 2/26/2010 | CVIG | Eli Lilly files automatic shelf covering debt, stock and preferreds
|
| 11/13/2009 | IG | Fitch cuts Eli Lilly outlook to negative
|
| 10/21/2009 | IG | Market Commentary: Westpac, BB&T price deals, primary watches earnings; spreads tighten; JPMorgan preferreds gain
|
| 3/17/2009 | IG | Market Commentary: Pfizer sells $13.5 billion bond issue; State Street, SoCal Edison price; Pfizer bonds tighten
|
| 3/17/2009 | IG | Market Commentary: Pfizer sells $13.5 billion bond issue; State Street, SoCal Edison price; Pfizer bonds tighten
|
| 3/6/2009 | IG | Market Commentary: Sour tone leaves primary market dry; secondary focuses on financials, FDIC-backed deals most traded
|
| 3/4/2009 | IG | Market Commentary: Pace slows, Appalachian power, NiSource Finance sell bonds; GE Capital wider on rating worries; Coke, Lilly gain
|
| 3/3/2009 | IG | S&P assigns Eli Lilly notes AA
|
| 3/3/2009 | IG | Moody's rates Eli Lilly notes A1
|
| 3/3/2009 | IG | Fitch gives Eli Lilly notes A+
|
| 3/3/2009 | IG | Market Commentary: Eli Lilly, Coca-Cola, PG&E, KfW, Cargill, State Street, Mississippi Power price; Lilly tightens, GE Capital weaker
|
| 3/3/2009 | IG | New Issue: Eli Lilly sells $2.4 billion notes in three tranches
|
| 11/24/2008 | IG | Fitch lowers Eli Lilly
|
| 11/21/2008 | IG | Moody's downgrades Lilly
|
| 10/21/2008 | IG | S&P: Eli Lilly unaffected
|
| 10/6/2008 | IG | S&P: Eli Lilly unchanged
|
| 10/6/2008 | IG | Moody's may cut Eli Lilly
|
| 10/6/2008 | IG | Fitch: Eli Lilly on watch
|
| 10/1/2008 | IG | Fitch affirms Eli Lilly
|
| 4/23/2008 | IG | Moody's rates Lilly's notes Aa3
|
| 9/26/2007 | IG | Fitch affirms Lilly
|
